AI assistant
Sending…
Tango Therapeutics, Inc. — Director's Dealing 2020
Nov 25, 2020
32459_dirs_2020-11-24_14793f5e-47ec-4c63-935d-a0c51ad31b36.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BCTG Acquisition Corp. (BCTG)
CIK: 0001819133
Period of Report: 2020-11-20
Reporting Person: BCTG Holdings, LLC (10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-11-20 | Common Stock | S | 2500 | $0.006 | Disposed | 4490950 | Direct |
| 2020-11-20 | Common Stock | S | 2500 | $0.006 | Disposed | 4488450 | Direct |
Footnotes
F1: On November 20, 2020, BCTG Holdings, LLC transferred 2,500 founder shares to an advisor at the original purchase price of the shares.
More from Tango Therapeutics, Inc.
Share Issue/Capital Change
2026
Jun 8
Regulatory Filings
2026
Jun 8
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 4
Board/Management Information
2026
May 13
Board/Management Information
2026
May 8
Annual Report
2026
Apr 17
Proxy Solicitation & Information Statement
2026
Apr 17
Board/Management Information
2026
Apr 15
Director's Dealing
2026
Mar 28
Regulatory Filings
2026
Mar 25